Wed 5/22/2013 22:05 ET DJIA 15307.17 79.60 0.52% SOLAR 23.77 1.90 8.01% GOLD 1365.50 12.10 0.88% Shanghai 2291.42 11.00 0.48% S&P 500 1655.35 13.74 0.83% BANKS 19.83 0.21 1.05% OIL 94.19 1.99 2.07% Nikkei 15879.03 255.65 1.61% NASDAQ 3463.30 38.44 1.11% SEMI 38.01 0.54 1.43% US/EU 0.78 0.01 0.39% Futures 1655.10 0.50 0.03%

Forum - Medivation - MDVN    Must-Do 101s AIO Message Earnings Estimate Insider Trade Upgrade/Downgrade Short Interest Quick Alerts Last Sales Stock Quote Real-Time Pre-Market After-Hours Tick By Tick Historical Quotes Stock Options News/Charts AIO Message News Blogs Basic Chart Pre-Market Chart After-Hours Chart Interactive P-V Plot Chart Charting Events Earning Date Conference Calls Stock Research TheLion.com Forum Profile SEC Filings Past Earnings Earnings Estimate 5-Yr Earn History Earning Whispers Balance Sheet Valuation Competitors Stats Ownership Ratios Performance Buy/Sell Rating Analysts Ratings Portfolio Owners Fund Buys & Sells CAPS Ratings Scouter Zacks Guided Targets Technical Indicator Trend Spotter Market Advisors Power Ratings

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add MDVN    From: Leoncina (Rep: 663) Date: 06/05/2011 13:17 Forum: Medivation - Msg #146 Thread #673238001 (Rec: 0) Medivation and Astellas Announce New Study Results Confirming Clinical Effects and Tolerability of MDV3100 in Advanced Prostate Cancer http://investors.medivation.com/releasedetail.cfm?ReleaseID=582749 Sent from my IPad Share This Post: What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Leoncina: Reward | Watch | IgnoreMDVN: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add MDVN

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.